Mea Kākau: Virginia Floyd
Lā O Ka Hana: 13 Aukake 2021
HōʻAno Hou I Ka Lā: 15 Nowemapa 2024
Anonim
NIACINAMIDE - IS IT WORTH THE HYPE? DERMATOLOGISTS WEIGH IN
Wikiō: NIACINAMIDE - IS IT WORTH THE HYPE? DERMATOLOGISTS WEIGH IN

Anter

ʻElua ʻano o ka wikamina B3. ʻO kekahi ʻano he niacin, a ʻo kekahi he niacinamide. Loaʻa ʻo Niacinamide i nā meaʻai he nui me ka hū, ka ʻiʻo, ka iʻa, ka waiū, nā hua manu, nā mea kanu ʻōmaʻomaʻo, nā pīni, a me nā hua cereal. ʻIke ʻia ʻo Niacinamide i loko o nā huaora B paʻakikī me nā huaʻai B ʻē aʻe. Niacinamide hiki ke hana ʻia i loko o ke kino mai ka diet niacin.

Mai hoʻohoka i ka niacinamide me ka niacin, NADH, ka nikotinamide riboside, ka inositol nicotinate, a me ka tryptophan. E ʻike i nā papa inoa ʻokoʻa no kēia mau kumuhana.

Lawe ʻia ʻo Niacinamide e ka waha no ka pale ʻana i ka hemahema o ka wikamina B3 a me nā ʻano pili e like me pellagra. Lawe ʻia hoʻi e ka waha no ka huehue, diabetes, maʻi ʻaʻai waha, osteoarthritis, a me nā ʻano ʻē aʻe he nui. Eia nō naʻe, ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i kēia mau hoʻohana.

Hoʻohana ʻia ʻo Niacinamide i ka ʻili no ka huehue, eczema, a me nā ʻano ʻili ʻē aʻe. ʻAʻole hoʻi he hōʻike maikaʻi e kākoʻo i kēia mau hoʻohana.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no NIACINAMIDE penei:


Pili paha ia no ...

  • ʻO kahi maʻi i hōʻemi ʻia e ka niacin deficit (pellagra). Ua ʻae ʻia ʻo Niacinamide e ka US Food and Drug Administration (FDA) no kēia mau hoʻohana. ʻOi aku ka Niacinamide ma mua o ka niacin no ka mea ʻaʻole ia he kumu "flushing," (ʻulaʻula, ʻili a ʻalalā), kahi hopena o ka hoʻomaʻamaʻa niacin.

E kūpono paha no ...

  • Huehue. Hōʻike ka noiʻi mua i ka lawe ʻana i nā papa i piha i ka niacinamide a me nā mea hana ʻē aʻe no 8 mau pule e hoʻomaikaʻi i ka ʻili i ka poʻe me ka huehue. Hōʻike nā noiʻi ʻē aʻe i ka hoʻopili ʻana i kahi kalima i loko o ka niacinamide e hoʻomaikaʻi ai i ka helehelena o ka ʻili i ka poʻe me ka huehue.
  • Diabetes. Hōʻike kekahi mau noiʻi e lawe ana i ka niacinamide i mea e pale aku ai i ka nalo ʻana o ka hana insulin i nā keiki a me nā mākua e hopohopo nei no ka maʻi diabetes type 1. Pale paha ia i ka nalo ʻana o ka hana insulin a hoʻoliʻiliʻi i ka mahele lāʻau o ka insulin e pono ai nā keiki i ʻike ʻia me ka maʻi diabetes type 1. Eia nō naʻe, ʻaʻole e pale ka niacinamide i ka ulu ʻana o ka maʻi diabetes type 1 i nā keiki kūpilikiʻi. I ka poʻe me ka maʻi diabetes 2, he mea kōkua ka niacinamide i ka pale ʻana i ka hana insulina a hoʻomaikaʻi i ka kaohi kō kō.
  • Nā pae kiʻekiʻe o ka phosphate i ke koko (hyperphosphatemia). Hiki ke hoʻokumu ʻia nā pae kiʻekiʻe o ka phosphate e ka hoʻohaʻahaʻa ʻana i ka hana o ka hakuʻala. I ka poʻe me ke kīnā ʻole o ka hakuʻala ma hemodialysis a he kiʻekiʻe nā pae o ke koko phosphate, ʻo ka lawe ʻana i ka niacinamide me he mea lā e kōkua i ka hoʻēmi ʻana i nā pae phosphate ke lawe ʻia me ka ʻole o nā mea paʻa phosphate.
  • Maʻi ʻaʻai Head a me ka ʻāʻī. Hōʻike ka noiʻi e lawe ana i ka niacinamide ʻoiai e loaʻa ana i ka radiotherapy a me kahi ʻano o ka lāʻau i kapa ʻia ʻo carbonogen hiki ke kōkua i ka mālama ʻana i ka ulu ulu a hoʻonui i ke ola i kekahi poʻe me ka maʻi ʻaʻai o ka larynx. Lawe i ka niacinamide ʻoiai ke loaʻa nei ka radiotherapy a me ka carbogen e like me ka mea e pōmaikaʻi ai ka poʻe me ka maʻi ʻaʻai o ka larynx a he anemia kekahi. Kōkua pū kekahi i ka poʻe i loaʻa nā tumors i hoʻonele ʻia i ka oxygen.
  • Maʻi ʻaʻai ʻili. ʻO ka lawe ʻana i ka niacinamide he mea kōkua ia e pale aku i ka maʻi ʻaʻai ʻili hou a i ʻole nā ​​kiko precancerous (actinic keratosis) mai ka hoʻokumu ʻana i ka poʻe me ka moʻolelo o ka maʻi ʻaʻai a i ʻole keratosis actinic.
  • ʻO Osteoarthritis. ʻO ka lawe ʻana i ka niacinamide me he mea lā e hoʻomaikaʻi i ka loli hui a hoʻoliʻiliʻi i ka ʻeha a me ka pehu ʻana i ka poʻe me ka osteoarthritis Eia kekahi, ʻo kekahi poʻe me ka osteoarthritis e lawe i ka niacinamide pono paha e lawe i nā lāʻau ʻeha.

ʻAʻole kūpono paha no ...

  • Tumo lolo. Hōʻike ka noiʻi mua i ka mālama ʻana i ka poʻe me nā tumors lolo i hoʻoneʻe ʻia me ka niacinamide, radiotherapy, a me ka carbogen ʻaʻole hoʻomaikaʻi i ke ola ke hoʻohālikelike ʻia i ka radiotherapy a i ʻole ka radiotherapy a me ka carbogen.
  • Kanesa maʻi ʻaʻai. ʻO ka mālama ʻana i ka poʻe me ka maʻi ʻaʻai pūhū me ka niacinamide, radiotherapy, a me ka carbogen ʻaʻole e hoʻoliʻiliʻi ka ulu ulu ʻana a hoʻomaikaʻi paha i ke ola ke hoʻohālikelike ʻia i ka radiotherapy a i ʻole ka radiotherapy a me ka carbogen.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

  • ʻO kahi maʻi maka e alakaʻi ai i ka nalo ʻana o ka ʻike i nā mākua makua (degeneration macular e pili ana i ka makahiki a i ʻole AMD). Hōʻike ka noiʻi mua i ka lawe ʻana i ka niacinamide, ka wikamina E, a me ka lutein no hoʻokahi makahiki e hoʻomaikaʻi ai i ka maikaʻi o ka hana ʻana o ka retina i ka poʻe me ka nalo ʻana o ka ʻike ma muli o ka retina.
  • ʻIli ʻili. Hōʻike ka noiʻi mua i ka hoʻopili ʻana i ka kirimaila i loko o 5% niacinamide i ka maka e hoʻomaikaʻi ai i ka blotchiness, nā ʻulī, ka paʻa, a me ka ʻulaʻula o nā wahine me ka ʻelemakule ʻili ma muli o ka pōʻino o ka lā.
  • Eczema (atopic dermatitis). Hōʻike ka noiʻi mua i ka noi ʻana i ka holika i loko o 2% niacinamide e hoʻoliʻiliʻi i ka nalo ʻana o ka wai a hoʻomaikaʻi i ka hydration, a hoʻemi i ka ʻulaʻula a me ka unahi ʻana, i ka poʻe me ka eczema.
  • Ka maʻi deficit-hyperactivity maʻi (ADHD). Aia kekahi mau hōʻike e pili ana i ka pono o ka niacinamide i hui pū ʻia me nā huaora ʻē aʻe no ka mālama ʻana iā ADHD.
  • ʻO ka ʻulaʻula i hoʻokumu ʻia e ka ʻeha a i ʻole ka ukiuki (erythema). Hōʻike ka noiʻi mua i ka noi ʻana i kahi kalima i loko o ka niacinamide e hoʻoliʻiliʻi i ka ʻulaʻula o ka ʻili, ka maloʻo, a me ka ʻino i hoʻokumu ʻia e ka huehue isotretinoin.
  • ʻO ka maʻi maʻi lōʻihi lōʻihi (ka maʻi maʻi kōkō a CKD paha). Hōʻike ka noiʻi mua i ka lawe ʻana i ka niacinamide ʻaʻole ia e kōkua i ka hoʻoliʻiliʻi i ka poʻe me nā maʻi puʻupaʻa.
  • Nā ʻili ʻili pouli ma ka maka (melasma). Hōʻike ka noiʻi mua i ka noi ʻana i ka moisturizer i loaʻa he 5% niacinamide a i ʻole 2% niacinamide me 2% tranexamic acid no 4-8 mau pule e hoʻomālamalama i ka ʻili i ka poʻe me nā ʻili ʻeleʻele o ka ʻili.
  • Ka maʻi ʻaʻai e hoʻomaka i nā hunaola keokeo (non-Hodgkin lymphoma). Hōʻike ka noiʻi mua i ka lawe ʻana i ka niacinamide ma ke ʻano he ʻāpana me ka lāʻau i kapa ʻia vorinostat e kōkua paha i ka poʻe me ka lymphoma e hele i ke kala.
  • ʻO kahi ʻano ʻili e ʻulaʻula i ka maka (rosacea). Hōʻike ka noiʻi mua i ka lawe ʻana i nā papa i piha i ka niacinamide a me nā mea hana ʻē aʻe no 8 mau pule e hoʻomaikaʻi i ka ʻili i ka poʻe me ka rosacea.
  • ʻIli, ʻili maka ma ka ʻili a me ka maka (seborrheic dermatitis). Hōʻike ka noiʻi mua i ka noi ʻana i kahi kalima i piha i ka niacinamide he 4% hiki ke hōʻemi i ka ʻulaʻula a me ka unahi ʻana o ka ʻili i ka poʻe me dermatitis seborrheic
  • ʻAlekohola.
  • Maʻi Alzheimer.
  • Pākuʻi.
  • E hōʻole i ka hoʻomanaʻo a me nā mākau noʻonoʻo e hana maʻamau me ka makahiki.
  • Kaumaha.
  • Piʻi koko kiʻekiʻe.
  • Maʻi maʻi.
  • Premenstrual Syndrome (PMS).
  • Nā kūlana ʻē aʻe.
Pono nā hōʻike hou aʻe e helu i ka niacinamide no kēia mau hoʻohana.

Hiki ke hana i ka Niacinamide mai ka niacin i ke kino. Hoʻololi ʻia ʻo Niacin i niacinamide ke lawe ʻia i nā mea i ʻoi aku i ka mea e pono ai ke kino. Hoʻopau maʻalahi ʻo Niacinamide i ka wai a lawe maikaʻi ʻia ke lawe ʻia e ka waha.

Koi ʻia ʻo Niacinamide no ka hana kūpono o nā momona a me nā kō i ke kino a mālama i nā hunaola olakino.

ʻAʻole like me ka niacin, ʻaʻohe hopena maikaʻi o ka niacinamide i nā momona a pono ʻole e hoʻohana ʻia no ka mālama ʻana i ke kiʻekiʻe o ke kolesterol a i ʻole nā ​​kiʻekiʻe momona i loko o ke koko. Ke lawe ʻia e ka waha: Niacinamide ʻo ia LIKELY SAFE no ka hapanui o nā mākua ke lawe ʻia i nā kālā i ʻōlelo ʻia. ʻAʻole like me ka niacin, ʻaʻole kumu niacinamide i ka flush. Eia nō naʻe, hiki i ka niacinamide ke kumu i nā hopena liʻiliʻi e like me ka huhū o ka ʻōpū, ka ʻaukā, dizziness, pehu, ʻimi a me nā pilikia ʻē aʻe. I mea e hōʻemi ai i ka hopena o kēia mau hopena, pono i nā mākua ke hōʻalo i ka lawe ʻana i ka niacinamide i nā kaha i ʻoi aku ma mua o 35 mg i kēlā me kēia lā.

Ke lawe ʻia nā lāʻau ma luna o 3 mau gika i kēlā me kēia lā o ka niacinamide, hiki i nā hopena ʻē aʻe koʻikoʻi ke kū. Hoʻopili kēia i nā pilikia o ke ake a i ʻole ke kō i ke koko kiʻekiʻe.

Ke hoʻopili ʻia i ka ʻili: Niacinamide ʻo ia SAFE MAU PONO. Hiki i ke kalima Niacinamide ke kumu i ke ahi, ʻili, a me ka ʻulaʻula.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: Niacinamide ʻo ia LIKELY SAFE no nā wahine hāpai a hānai hānai i ka wā i lawe ʻia i nā helu i ʻōlelo ʻia. ʻO ka nui o ka niacin i koi ʻia no nā wahine hāpai a hānai hānai paha ʻo 30 mg i kēlā me kēia lā no nā wahine ma lalo o 18 mau makahiki, a 35 mg i kēlā me kēia lā no nā wahine ma mua o 18 mau makahiki.

Nā keiki: Niacinamide ʻo ia LIKELY SAFE ke lawe ʻia e ka waha i nā helu i paipai ʻia no kēlā me kēia pae makahiki. Akā pono nā keiki e hōʻalo i ka lawe ʻana i nā lāʻau o ka niacinamide ma luna o nā palena o kēlā me kēia lā, ʻo 10 mg no nā keiki 1-3 mau makahiki, 15 mg no nā keiki 4-8 mau makahiki, 20 mg no nā keiki 9-13 mau makahiki, a 30 mg no nā keiki 14-18 mau makahiki.

Nā Pāhoihoi: Hiki i ka Niacinamide ke hana i nā maʻi āpau i mea ʻoi loa no ka mea kumu lākou i ka histamine, ke kemikona e pili ana i nā ʻōnaehana maʻi, e hoʻokuʻu ʻia.

Diabetes: Hiki i ka Niacinamide ke hoʻonui i ke kō kō. ʻO ka poʻe me ka maʻi diabetes e lawe i ka niacinamide e nānā pono i kā lākou kō kō.

Maʻi maʻi gallbladder: Niacinamide paha e hōʻino i ka maʻi o ka gallbladder.

Goute: Hiki i nā niacinamide nui ke lawe mai i ka gout.

Dialysis hakuʻala: ʻO ka lawe ʻana i ka niacinamide me he mea lā e hoʻonui i ka makaʻu o nā pae platelet haʻahaʻa i ka poʻe me ke kīnā ʻole o ka puʻuwai e noho ana ma ka dialysis.

Maʻi maʻi ate: Hoʻonui ka Niacinamide i ka hōʻino o ke ake. Mai hoʻohana ia inā loaʻa ʻoe i ka maʻi ate.

ʻŌpū ʻōpū a ʻōpū paha: Niacinamide paha e ʻoi aku ka maikaʻi o ka ulcer. Mai hoʻohana iā ia inā loaʻa iā ʻoe nā maʻi ulcer.

ʻOki kino: Hiki iā Niacinamide ke hoʻopili i ka kaohi kō kō i ka wā a ma hope o ke kaha ʻana. E hoʻōki i ka lawe ʻana i ka niacinamide ma kahi o 2 mau pule ma mua o ka hōʻoki ʻia ʻana.

Kānāwai
E akahele me kēia hui ʻana.
Carbamazepine (Tegretol)
Ua wāwahi ʻia ʻo Carbamazepine (Tegretol) e ke kino. Aia kekahi hopohopo e hōʻemi paha ka niacinamide i ka wikiwiki o ke kino e wāwahi i ka carbamazepine (Tegretol). Akā ʻaʻole lawa ka ʻike e ʻike ai inā he mea nui kēia.
Nā lāʻau i hiki ke hōʻeha i ke ake (Hepatotoxic drug)
Hiki iā Niacinamide ke hōʻeha i ke ake, keu hoʻi ke hoʻohana ʻia i nā kau kiʻekiʻe. Lawe pū me ka niacinamide me nā lāʻau e hōʻino paha i ke akepaʻa ke hoʻonui i ka hopena o ka hōʻino o ke ake. Mai lawe i ka niacinamide inā lawe ʻoe i kahi lāʻau e hiki ai ke hōʻeha i ke ake.

ʻO kekahi mau lāʻau e hiki ai ke hōʻeha i ke akepaʻa me ka acetaminophen (Tylenol a me nā mea ʻē aʻe), amiodarone (Cordarone), carbamazepine (Tegretol), isoniazid (INH), methotrexate (Rheumatrex), methyldopa (Aldomet), fluconazole (Diflucan), itraconazole (Sporanozole (Sporlucan), itraconazole (Sporanozole (Spiflucan), itraconazole (Spor)) erythromycin (Erythrocin, Ilosone, kekahi), phenytoin (Dilantin), lovastatin (Mevacor), pravastatin (Pravachol), simvastatin (Zocor), a me nā mea ʻē aʻe he nui.
Nā lāʻau i hoʻolohi i ke kō ʻana o ke koko (Anticoagulant / Antiplatelet drug)
Niacinamide paha e hoʻolohi i ke kō ʻana o ke koko. ʻO ka lawe ʻana i ka niacinamide me nā lāʻau e hōʻemi ai hoʻi i ka ʻōpala ʻana e hoʻonui ai i ka manawa o ka palapū a me ke kahe ʻana o ke kahe.

ʻO kekahi mau lāʻau e lohi ai ke kāpili ʻana o ke koko me aspirin, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, indomethacin (Indocin), ticlopidine (Ticlid), warfarin (Coumadin), a me nā mea ʻē aʻe.
Primidone (Mysoline)
Ua wāwahi ʻia ʻo Primidone (Mysoline) e ke kino. Aia kekahi hopohopo e hōʻemi paha ka niacinamide i ka wikiwiki o ke kino e haki i ka primidone (Mysoline). Akā ʻaʻole lawa ka ʻike e ʻike ai inā he mea nui kēia.
ʻO nā lau nahele a me nā mea hoʻopili e hōʻino paha i ke ake
Hiki i ka Niacinamide ke kumu i ka hōʻino o ke ake, keu hoʻi ke hoʻohana ʻia i nā ʻoi kiʻekiʻe. Lawe i ka niacinamide me nā mea kanu ʻē aʻe a i ʻole nā ​​mea hoʻopili e hōʻino ai i ke ake ke hoʻonui i kēia pilikia. ʻO kekahi o kēia huahana me androstenedione, lau borage, chaparral, comfrey, dehydroepiandrolone (DHEA), germander, kava, pennyroyal aila, ʻulaʻena hū, a me nā mea ʻē aʻe.
ʻO nā lau nahele a me nā mea hoʻopili e lohi ai i ke kāpili ʻana o ke koko
Niacinamide paha e hoʻolohi i ke kō ʻana o ke koko. Ke hoʻohana nei i ka niacinamide me nā mea kanu a me nā mea hoʻopili ʻē aʻe e lohi ai i ka hoʻopili ʻia ʻana o ke koko e hoʻonui i ka makaʻu o ke kahe ʻana i kekahi poʻe. ʻO kekahi mau mea kanu ʻē aʻe o kēia ʻano me Angelica, clove, danshen, kālika, ginger, Panax ginseng, a me nā mea ʻē aʻe.
ʻAʻole ʻike ʻia nā launa me nā meaʻai.
Ua aʻo ʻia nā mahele aʻe i ka noiʻi ʻepekema:

NA MAKAHIKI

E ka waha:
  • Generala: ʻAʻole hiki i kekahi huahana hoʻopihapiha papa inoa i ka papa inoa niacinamide ma ka lepili. Ma ka hakahaka, hiki ke helu ʻia ma lalo o ka niacin. Ana ʻia ʻo Niacin i nā mea like niacin (NE). ʻO ka mahele lāʻau o 1 mg o ka niacinamide e like ia me 1 mg NE. ʻO nā haʻawina hoʻolāʻau ʻai e koi ʻia i kēlā me kēia lā (RDA) no ka niacinamide i nā mākua he 16 mg NE no nā kāne, 14 mg NE no nā wahine, 18 mg NE no nā wahine hāpai, a me 17 mg NE no nā wahine lactating.
  • No ka huehue: Nā papa i loaʻa he 750 mg o ka niacinamide, 25 mg o ka zinc, 1.5 mg keleawe, a me 500 mcg o ka folic acid (Nicomide) hoʻokahi a ʻelua mau manawa i hoʻohana ʻia i kēlā me kēia lā. Eia kekahi, 1-4 papa i piha i ka niacinamide, azelaic acid, zinc, vitamin B6, keleawe, a me folic acid (NicAzel, Elorac Inc., Vernon Hills, IL) i lawe ʻia i kēlā me kēia lā.
  • No nā hōʻailona hemahema o ka wikamina B3 e like me pellagra: Hāʻawi ʻia ʻo 300-500 mg i kēlā me kēia lā o ka niacinamide i nā kōpana māhele.
  • No ka maʻi kō: Niacinamide 1.2 gram / m2 (kahi o ke kino) a i ʻole 25-50 mg / kg e hoʻohana ʻia i kēlā me kēia lā no ka lohi o ka holomua o ka maʻi diabetes 1. Eia pū kekahi, 0.5 mau māmā o ka niacinamide ʻekolu mau manawa i kēlā me kēia lā e hoʻohana ai e hoʻolohi i ka holomua o ka maʻi diabetes type 2.
  • No nā pae kiʻekiʻe o ka phosphate i ke koko (hyperphosphatemia): Niacinamide mai 500 mg a i 1.75 gram i kēlā me kēia lā i nā mahele i hoʻokaʻawale ʻia e hoʻohana ʻia no 8-12 mau pule.
  • No ka maʻi ʻaʻai o ka larynx: Hāʻawi ʻia ʻo 60 mg / kg o ka niacinamide i ka 1-1.5 mau hola ma mua o ka hemo ʻana o ka carbogen (2% carbon dioxide a me 98% oxygen) ma mua a i ka wā o radiotherapy.
  • No nā maʻi ʻili ʻē aʻe ma mua o ka melanoma: 500 mg o ka niacinamide hoʻokahi a ʻelua paha manawa i kēlā me kēia lā no 4-12 mau mahina.
  • No ka mālama ʻana i ka osteoarthritis: 3 gram o ka niacinamide i kēlā me kēia lā i nā mahele i hoʻokaʻawale ʻia no 12 mau pule.
MA KA ʻili:
  • Huehue: He gel nona ka 4% niacinamide ʻelua mau lā i kēlā me kēia lā.
KEIKI

  • Generala: ʻO nā haʻawina ʻai no kēlā me kēia lā no nā niacinamide he 2 mg no nā keiki 0-6 mau mahina, 4 mg NE no nā keiki pēpē 7-12 mau makahiki, 6 mg NE no nā keiki 1-3 mau makahiki, 8 mg NE no nā keiki 4-8 mau makahiki, 12 mg NE no nā keiki 9-13 mau makahiki, 16 mg NE no nā kāne 14-18 mau makahiki, a 14 mg NE no nā wahine 14-18 mau makahiki.
  • No ka huehue: I nā keiki ma ka liʻiliʻi he 12 mau makahiki, 1-4 papa i piha me ka niacinamide, ʻākela azelaic, zinc, wikamina B6, keleawe, a me folic acid (NicAzel, Elorac Inc., Vernon Hills, IL) i kēlā me kēia lā.
  • No ka pellagra: Hāʻawi ʻia ʻo 100-300 mg o ka niacinamide i kēlā me kēia lā i nā mahele i hoʻokaʻawale ʻia.
  • No ka maʻi diabetes type 1: 1.2 gram / ka m2 (Kahi ākea o ke kino) a i ʻole 25-50 mg / kg o ka niacinamide e hoʻohana ʻia i kēlā me kēia lā no ka lohi o ka holomua a i ʻole ke pale ʻana i ka maʻi diabetes 1.
3-Pyridine Carboxamide, 3-Pyridinecarboxamide, Amide de lʻAcide Nicotinique, B Complex Wikamina, Complexe de Vitamines B, Niacinamida, Nicamid, Nicosedine, Nicotinamide, Nicotinic Acid Amide, Nicotylamidum, Pyridine-3-carboxamide, Vitamin B3, Vitamina B , Vitamine B3.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.


  1. Zhang Y, Ma T, Zhang P. Ka hoʻokō ʻana a me ka palekana o ka nicotinamide ma ka phosphore metabolism i nā mea maʻi hemodialysis: He loiloi ʻōnaehana a me nā meta-analysis. Lapaʻau (Baltimore). 2018; 97: e12731. Nānā kiʻi ʻole.
  2. Cannizzaro MV, Dattola A, Garofalo V, Del Duca E, Bianchi L. Ka hoʻēmi ʻana i ka ʻaoʻao ʻili isotretinoin ʻaoʻao: ka pono o 8% omega-ceramides, nā kō kōkoʻolako, 5% niacinamide hui kalima i nā maʻi huehue. G Ital Dermatol Venereol. 2018; 153: 161-164. Nānā kiʻi ʻole.
  3. Ke kikowaena no ka hana lapaʻau ma NICE (UK). ʻO Hyperphosphataemia ma ka maʻi maʻi maʻi maʻi: Ka mālama ʻana i ka Hyperphosphataemia i nā mea maʻi me ka pae 4 a i ʻole 5 maʻi maʻi maʻi maʻi. National Institute no ke olakino a me ka mālama maikaʻi: nā alakaʻi alakaʻi. Manchester: National Institute no ke olakino a me ka mālama maikaʻi (UK); 2013 Mar.
  4. Cheng SC, Young DO, Huang Y, Delmez JA, Coyne DW. ʻO kahi hoʻokolohua kaulike ʻole, makapō makapō, kahi placebo-kāohi ʻia o ka niacinamide no ka hoʻoliʻiliʻi o ka phosphore i nā mea maʻi hemodialysis. ʻO Clin J Am Soc Nefrol. 2008 Jul; 3: 1131-8. Nānā kiʻi ʻole.
  5. ʻO Hoskin PJ, Rojas AM, Bentzen SM, Saunders MI. ʻO Radiotherapy me ka carbogen concurrent a me ka nicotinamide i ka maʻi kanesa o ka maʻi ʻaʻai. ʻO J Clin Oncol. 2010 Nov 20; 28: 4912-8. Nānā kiʻi ʻole.
  6. Surjana D, Halliday GM, Martin AJ, Moloney FJ, Damian DL. ʻO ka nicotinamide waha e hoʻoliʻiliʻi i nā keratoses actinic i ka hoʻokolohua II i nā hoʻokolohua hoʻomalu kaulike ʻia. ʻO J Invest Dermatol. 2012 Mei; 132: 1497-500. Nānā kiʻi ʻole.
  7. ʻO Omidian M, Khazanee A, Yaghoobi R, Ghorbani AR, Pazyar N, Beladimousavi SS, Ghadimi M, Mohebbipour A, Feily A. Ka hopena therapeutic o ka waha o ka nicotinamide ma ka pruritus uremic refactory: kahi hoʻokolohua kaulike ʻole. ʻO Saudi J Kidney Dis Transpl. 2013 Sep; 24: 995-9. Nānā kiʻi ʻole.
  8. Nijkamp MM, Span PN, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende PL, de Jong M, van der Kogel AJ, Bussink J, Kaanders JH. ʻO ka ʻōlelo a ka receptor ulu Epidermal i ka maʻi ʻaʻai laryngeal wānana i ka hopena o ka hoʻololi hypoxia ma ke ʻano he mea hoʻohui i ka radiotherapy wikiwiki i kahi hoʻokolokolo i hoʻokolokolo ʻia. Eur J Ka maʻi ʻaʻai. 2013 ʻOkakopa; 49: 3202-9. Nānā kiʻi ʻole.
  9. Martin AJ, Chen A, Choy B, et al. ʻO ka nicotinamide waha e hoʻoliʻiliʻi i ka maʻi ʻaʻai actinic: kahi pae 3 hoʻokolokolo makapō papalua i hoʻonohonoho ʻia i hoʻonohonoho ʻia. ʻO J Clin Oncol 33, 2015 (suppl; abstr 9000).
  10. Lee DH, Oh IY, Koo KT, Suk JM, Jung SW, Park JO, Kim BJ, Choi YM. ʻO ka hōʻemi ʻana i ka hyperpigmentation maka ma hope o ka hoʻomaʻamaʻa ʻana me ka hui pū ʻia ʻana o ka niacinamide topical a me ka tranexamic acid: kahi hoʻokolohua i hoʻokolohua ʻole ʻia, pālua makapō ʻia. ʻĀina Res Technol. 2014 Mei; 20: 208-12. Nānā kiʻi ʻole.
  11. Khodaeiani E, Fouladi RF, Amirnia M, Saeidi M, Karimi ER. Kumuhana 4% nikotinamide vs. 1% clindamycin i ka huehue huehue huehue vulgaris. Int J Dermatol. 2013 ʻAuk; 52: 999-1004. Nānā kiʻi ʻole.
  12. ʻO Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Lawe iā RP, de Bree R, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH. Hoʻonui i ke ola manuahi hoʻi me ARCON no nā mea maʻi anemia me ka maʻi ʻaʻa laryngeal. ʻO Clin Cancer Res. 2014 Malaki 1; 20: 1345-54. Nānā kiʻi ʻole.
  13. ʻO Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Marres HA, de Bree R, van der Kogel AJ, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH. ʻO radiotherapy wikiwiki me ka carbogen a me ka nikotinamide no ka maʻi ʻaʻai laryngeal: nā hopena o kahi hoʻokolokolo III i hoʻokolohua ʻole ʻia. ʻO J Clin Oncol. 2012 Mei 20; 30: 1777-83. Nānā kiʻi ʻole.
  14. Fabbrocini G, Cantelli M, Monfrecola G. Topical nikotinamide no seborrheic dermatitis: kahi hāmeʻa e wehe ʻia. Hoʻomaʻamaʻa ʻo J Dermatolog. 2014 Iune; 25: 241-5. Nānā kiʻi ʻole.
  15. Eustace A, Irlam JJ, Taylor J, Denley H, Agrawal S, Choudhury A, Ryder D, Ord JJ, Harris AL, Rojas AM, Hoskin PJ, West CM. Ua wānana ʻo Necrosis i ka pōmaikaʻi mai ka hypoxia-modifying therapy i nā mea maʻi me ka maʻi ʻaʻai nui o ka maʻi ʻaʻai i kākau inoa ʻia i loko o ka hoʻokolohua pae III. ʻO Radiother Oncol. 2013 Jul; 108: 40-7. Nānā kiʻi ʻole.
  16. Amengual JE, Clark-Garvey S, Kalac M, Scotto L, Marchi E, Neylon E, Johannet P, Wei Y, Zain J, O'Connor OA. ʻO Sirtuin a me ka papa-papa I / II deacetylase (DAC) ka mea pāpā he synergistic i loko o nā hiʻohiʻona preclinical a me nā noiʻi maʻi o lymphoma. Koko. 2013 Sep 19; 122: 2104-13. Nānā kiʻi ʻole.
  17. Shalita AR, Falcon R, Olansky A, Iannotta P, Akhavan A, Lā D, Janiga A, Singri P, Kallal JE. ʻO ka mālama ʻana i ka huehue hoʻoweliweli me kahi mea hoʻopihapiha papa kuhikuhi meaʻai. ʻO J Drugsol Dermatol. 2012; 11: 1428-33. Nānā kiʻi ʻole.
  18. Falsini, B., Piccardi, M., Iarossi, G., Fadda, A., Merendino, E., a me Valentini, P. Ka hopena o ka hoʻopili ʻia ʻana o ka manawa pōkole ma ka hana macular i ka maculopathy e pili ana i nā makahiki: kahi papa pailaka me kahi loiloi electrophysiologic. Ophthalmology 2003; 110: 51-60. Nānā kiʻi ʻole.
  19. Elliott RB, Pilcher CC, Stewart A, Fergusson D, McGregor MA. Ka hoʻohana ʻana i ka nikotinamide i ka pale ʻana i ka maʻi diabetes type 1. ʻO Ann N Y Acad Sci. 1993; 696: 333-41. Nānā kiʻi ʻole.
  20. ʻO Rottembourg JB, Launay-Vacher V, Massard J. Thrombocytopenia i hoʻokomo ʻia e nicotinamide i nā mea maʻi hemodialysis. Int. 2005; 68: 2911-2. Nānā kiʻi ʻole.
  21. Takahashi Y, Tanaka A, Nakamura T, et al. Hoʻopau ʻo Nicotinamide i ka hyperphosphatemia i nā mea maʻi hemodialysis. Int. 2004; 65: 1099-104. Nānā kiʻi ʻole.
  22. Soma Y, Kashima M, Imaizumi A, et al. Nā hopena hoʻoluʻu o ka topical nicotinamide ma ka ʻili maloʻo atopic. Int J Dermatol. 2005; 44: 197-202. Nānā kiʻi ʻole.
  23. Powell ME, Hill SA, Saunders MI, Hoskin PJ, Chaplin DJ. Hoʻonui ʻia ke kahe koko kanaka e ka nicotinamide a me ka hanu carbogen. ʻO Res. 1997; 57: 5261-4. Nānā kiʻi ʻole.
  24. ʻO Hoskin PJ, Rojas AM, Phillips H, Saunders MI. ʻO ka maʻi ākea a me ka hopena o ka mālama ʻana i ka maʻi kanesa holomua me ka radiotherapy wikiwiki, carbogen, a me ka nicotinamide. Kanesa. 2005; 103: 2287-97. Nānā kiʻi ʻole.
  25. Niren NM, Torok HM. ʻO ka hoʻomaikaʻi ʻo Nicomide i ke aʻo ʻana i nā hopena maʻi (NICOS): nā hopena o ka hoʻokolokolo he 8 mau pule. Cutis. 2006; 77 (1 Hōʻawi): 17-28. Nānā kiʻi ʻole.
  26. Kamal M, Abbasy AJ, Muslemani AA, Bener A. Ka hopena o ka nicotinamide i nā keiki diabetic type 1 hou i ʻike ʻia. ʻO Acta Pharmacol Sin. 2006; 27: 724-7. Nānā kiʻi ʻole.
  27. Olmos PR, Hodgson MI, Maiz A, et al. Pale aku ʻo Nicotinamide i ka pane o ka iniha pae mua (FPIR) a pale aku i ka maʻi maʻi ma nā kekelē laeoʻo o nā diabetic type-1. Hoʻomaʻamaʻa ʻo Diabetes Res Clin. 2006; 71: 320-33. Nānā kiʻi ʻole.
  28. Gale EA, Bingley PJ, Emmett CL, Collier T; ʻO ka hui ʻEuropa Nicotinamide Diabetes Intervention Trial (ENDIT). ʻO ka European Nicotinamide Diabetes Intervention Trial (ENDIT): kahi hoʻokolohua hoʻokolohua kaulike ʻia o ka hana ma mua o ka hoʻomaka ʻana o ka maʻi diabetes 1. Lancet. 2004; 363: 925-31. Nānā kiʻi ʻole.
  29. Cabrera-Rode E, Molina G, Arranz C, Vera M, et al. Ka hopena o ka nikotinamide maʻamau i ka pale ʻana i ka maʻi diabetes type 1 i nā kekelē mua o nā kānaka me ka maʻi diabetes type 1. Pāʻokoʻa ola. 2006; 39: 333-40. Nānā kiʻi ʻole.
  30. Hakozaki T, Minwalla L, Zhuang J, et al. ʻO ka hopena o ka niacinamide i ka hōʻemi ʻana i ka pigmentation cutane a me ke kaomi ʻana i ka lawe melanosome. ʻO Br J Dermatol. 2002 Jul; 147: 20-31. Nānā kiʻi ʻole.
  31. ʻO Bissett DL, ʻO Oblong JE, Berge CA. Niacinamide: A B wikamina i hoʻomaikaʻi i ka ʻelemakule helehelena o ka ʻili. ʻO Dermatol Surg. 2005; 31 (7 Pt 2): 860-5; kūkākūkā 865. Nānā i ka abstract.
  32. ʻO Jorgensen J. Pellagra paha ma muli o ka pyrazinamide: ke hoʻomohala ʻana i ka manawa o ka chemotherapy o tuberculosis. Int J Dermatol 1983; 22: 44-5. Nānā kiʻi ʻole.
  33. Swash M, Roberts AH. Hiki i ka encephalopathy like pellagra me ka ethionamide a me cycloserine. Pūʻulu 1972; 53: 132. Nānā kiʻi ʻole.
  34. Brooks-Hill RW, Bishop ME, Vellend H. Pellagra-e like me ka encephalopathy e hoʻopiʻi ana i kahi lāʻau lapaʻau he nui no ka mālama ʻana i ka maʻi pulmonary ma muli o Mycobacterium avium-intracellulare (leka). ʻAm Rev Resp Dis 1985; 131: 476. Nānā kiʻi ʻole.
  35. Visalli N, Cavallo MG, Signore A, et al. ʻO kahi hoʻokolohua hoʻokolohua kaulike waena o ʻelua mau kaha like ʻole o ka nikotinamide i nā mea maʻi me ka maʻi diabetes type 1 hou loa (ka IMDIAB VI). Diabetes Metab Res Rev 1999; 15: 181-5. Nānā kiʻi ʻole.
  36. ʻO Bourgeois BF, Dodson WE, Ferrendelli JA. Nā hana ma waena o primidone, carbamazepine, a me nikotinamide. ʻO Neurology 1982; 32: 1122-6. Nānā kiʻi ʻole.
  37. Papa CM. Niacinamide a me acanthosis nigricans (leka). Arch Dermatol 1984; 120: 1281. Nānā kiʻi ʻole.
  38. ʻO Winter SL, Boyer JL. Hepatic hoʻoweliweli mai ka nui mahele lāʻau o ka wikamina B3 (nikotinamide). N Engl J Med 1973; 289: 1180-2. Nānā kiʻi ʻole.
  39. ʻO McKenney J. Nā manaʻo hou e pili ana i ka hoʻohana ʻana o ka niacin i ka mālama ʻana i nā maʻi lipid. Arch Intern Med 2004; 164: 697-705. Nānā kiʻi ʻole.
  40. Ke hāpai nei i ka hoʻohana ʻana iā HDL a me Niacin. Palapala a ka Pharmacist's Letter / Prescriber's 2004; 20: 200504.
  41. Hoskin PJ, Stratford MR, Saunders MI, et al. Ka hoʻoponopono ʻana o ka nicotinamide i ka pakuhi: nā pharmacokinetics, ka piʻi ʻana o ka hopena, a me nā mea ʻino kino. Int J Radiat Oncol Biol Phys 1995; 32: 1111-9. Nānā kiʻi ʻole.
  42. Fatigante L, Ducci F, Cartei F, et al. Hoʻohui ʻia ʻo Carbogen a me nicotinamide me ka radiotherapy maʻamau ʻole i ka glioblastoma multiforme: kahi hana maʻamau hou. Int J Radiat Oncol Biol Phys 1997; 37: 499-504. Nānā kiʻi ʻole.
  43. Miralbell R, Mornex F, Greiner R, et al. ʻO radiotherapy wikiwiki, carbogen, a me nicotinamide i glioblastoma multiforme: hōʻike o ka European Organization for Research and Treat of Cancer trial 22933. J Clin Oncol 1999; 17: 3143-9. Nānā kiʻi ʻole.
  44. Anona ʻO Monakona Niacinamide. Alt Med Rev 2002; 7: 525-9. Nānā kiʻi ʻole.
  45. Haslam RH, Dalby JT, Rademaker AW. Nā hopena o ka megavitamin therapy ma luna o nā keiki me ka ʻike deficit maʻi. Nā Pediatrics 1984; 74: 103-11 .. Nānā i ka abstract.
  46. Papa Hoʻolālā Meaʻai a me Nutr, Institute of Medicine. Nā ʻai kuhikuhi papaʻai no Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, a me Choline. Wakinekona, DC: National Academy Press, 2000. Loaʻa ma: http://books.nap.edu/books/0309065542/html/.
  47. Shalita AR, Smith JG, Parish LC, et al. Hoʻohālikelike ʻia ka nicotinamide kumuhana me ka gel clindamycin i ka mālama ʻana i nā huehue huehue vulgaris. Int J Dermatol 1995; 34: 434-7. Nānā kiʻi ʻole.
  48. ʻO McCarty MF, ʻo Russell AL. Niacinamide therapy no osteoarthritis - hōʻemi paha ia i ka hoʻokomo ʻana o ka nitric oxide synthase e interleukin 1 i nā chondrocytes? Med Hypotheses 1999; 53: 350-60. Nānā kiʻi ʻole.
  49. ʻO Jonas WB, Rapoza CP, Blair WF. ʻO ka hopena o ka niacinamide ma osteoarthritis: kahi pailota. ʻO Inflamm Res 1996; 45: 330-4. Nānā kiʻi ʻole.
  50. Polo V, Saibene A, Pontiroli AE. Hoʻomaikaʻi ʻo Nicotinamide i ke kuhi ʻana o ka insulin a me ka mālama ʻana i ka metabolic i nā ʻano maʻi diabetic ʻano wīwī 2 me ka lua ʻole o ka sulphonylureas. ʻO Acta Diabetol 1998; 35: 61-4. Nānā kiʻi ʻole.
  51. Greenbaum CJ, Kahn SE, Palmer JP. Nā hopena a Nicotinamide e pili ana i ka glucose glucose i nā kumuhana i ka makaʻu no ka IDDM. Diabetes 1996; 45: 1631-4. Nānā kiʻi ʻole.
  52. Pozzilli P, Browne PD, Kolb H. Meta-nānā ʻana i ka mālama ʻana i ka nicotinamide i nā mea maʻi me ka IDDM hoʻomaka hou. ʻO nā Nicotinamide Trialists. Mālama Diabetes 1996; 19: 1357-63. Nānā kiʻi ʻole.
  53. Pozzilli P, Visalli N, Signore A, et al. ʻO ka hoʻāʻo makapō pālua o ka nikotinamide i ka IDDM hoʻomaka mua (ka IMDIAB III hoʻopaʻa haʻawina). Diabetologia 1995; 38: 848-52. Nānā kiʻi ʻole.
  54. Visalli N, Cavallo MG, Signore A, et al. ʻO kahi hoʻokolohua hoʻokolohua kaulike waena o ʻelua mau kaha like ʻole o ka nikotinamide i nā mea maʻi me ka maʻi diabetes type 1 hou loa (ka IMDIAB VI). Diabetes Metab Res Rev 1999; 15: 181-5. Nānā kiʻi ʻole.
  55. Pozzilli P, Visalli N, Cavallo MG, et al. Loaʻa nā hopena like me ka Vitamin E a me ka nicotinamide i ka mālama ʻana i ke koena beta cell i ka maʻi diabetes e pili ana i ka insulin. Eur J Endocrinol 1997; 137: 234-9. Nānā kiʻi ʻole.
  56. Lampeter EF, Klinghammer A, Scherbaum WA, a me al. Ke aʻo ʻana a Deutsche Nicotinamide Intervention Study: kahi hoʻāʻo e pale aku i ka maʻi diabetes type 1. Pūʻulu DENIS. Diabetes 1998; 47: 980-4. Nānā kiʻi ʻole.
  57. Elliott RB, Pilcher CC, Fergusson DM, Stewart AW. Kahi hoʻonohonoho lehulehu e pale ai i ka maʻi diabetes e pili ana i ka insulin me ka hoʻohana ʻana i ka nicotinamide. ʻO J Pediatr Endocrinol Metab 1996; 9: 501-9. Nānā kiʻi ʻole.
  58. ʻO Gale EA. ʻO ke kumumanaʻo a me ka hoʻomaʻamaʻa ʻana o nā hoʻokolohua nicotinamide i ka maʻi diabetes 1 ma mua. ʻO J Pediatr Endocrinol Metab 1996; 9: 375-9. Nānā kiʻi ʻole.
  59. Kolb H, Burkart V. Nicotinamide i ka maʻi diabetes type 1. Nānā hou ʻia ka ʻano hana. Mālama Diabetes 1999; 22: B16-20. Nānā kiʻi ʻole.
  60. ʻAmelika Hui Pū ʻIa o nā Pharmacist olakino. ʻO ka ASHP Therapeutic Position Statement e pili ana i ka hoʻohana palekana o ka niacin i ka mālama ʻana i nā dislipidemias. ʻO Am J Health Syst Pharm 1997; 54: 2815-9. Nānā kiʻi ʻole.
  61. ʻO Garg A, Grundy SM. ʻO ka waikawa Nicotinic e like me ka hoʻomaʻamaʻa no ka dyslipidemia i loko o ka mimikō non-insulin-dependant. JAMA 1990; 264: 723-6. Nānā kiʻi ʻole.
  62. ʻO Crouse JR III. Nā hanana hou i ka hoʻohana ʻana o ka niacin no ka mālama ʻana i ka hyperlipidemia: nā manaʻo hou i ka hoʻohana ʻana i kahi lāʻau kahiko. ʻO Coron Artery Dis 1996; 7: 321-6. Nānā kiʻi ʻole.
  63. ʻO Brenner A. Nā hopena o nā megadoses o nā wikamina paʻakikī B i wae ʻia i nā keiki me ka hyperkinesis: nā noiʻi i kāohi ʻia me ka ukali wā lōʻihi. J Learn Disabil 1982; 15: 258-64. Nānā kiʻi ʻole.
  64. ʻO Yates AA, Schlicker SA, Suitor CW. Nā ʻai kuhikuhi papaʻai: Ke kumu hou no nā ʻōlelo paipai no ka puna a me nā mea pili e pili ana, nā wikamina B, a me choline. ʻO J Am Diet Assoc 1998; 98: 699-706. Nānā kiʻi ʻole.
  65. ʻO Shils ME, ʻo Olson JA, ʻo Shike M, ʻo Ross AC, nā hua. Nūhou hou i ke olakino a me nā maʻi. 9th ed. ʻO Baltimore, MD: Williams & Wilkins, 1999.
  66. ʻO Harvengt C, Desager JP. Hoʻonui ka HDL-cholesterol i nā kumuhana normolipaemic ma khellin: kahi papa pailaka. Int J Clin Pharmacol Res 1983; 3: 363-6. Nānā kiʻi ʻole.
  67. Hardman JG, Limbird LL, Molinoff PB, eds. ʻO Goodman lāua ʻo Gillman's The Base Pharmacological of Therapeutics, 9th ed. Nu Ioka, NY: McGraw-Hill, 1996.
  68. ʻO McEvoy GK, hoʻoponopono. ʻO ka ʻike ʻo AHFS Ka lāʻau. Bethesda, MD: ʻAmelika Hui Pū ʻIa o Health-System Pharmacists, 1998.
  69. Blumenthal M, ed. ʻO ke Komikina Kelemania E Monographs: Alakaʻi Therapeutic i nā lāʻau Laʻau. Trans. S. Klein. ʻO Boston, MA: ʻAmelika Botanical Council, 1998.
Nānā hope - 10/05/2020

Hoihoi Ma Ka Pūnaewele

ʻO Bronchoscopy a me Bronchoalveolar Lavage (BAL)
Kino PaʻA

ʻO Bronchoscopy a me Bronchoalveolar Lavage (BAL)

ʻO Broncho copy kahi hana e hiki ai i ka mea lawelawe olakino ke nānā aku i kou mau māmā. Hoʻohana ia i kahi paipu lahilahi, kukui i kapa ʻia he broncho cope. Hoʻokomo ʻia ka paipu ma ka waha a me ka ...
Maʻi ʻaʻai kala
Kino PaʻA

Maʻi ʻaʻai kala

ʻO ka maʻi ʻaʻai Colorectal ka maʻi ʻaʻai e hoʻomaka i loko o ka ʻōpū nui (kolona) a i ʻole ke kiko (ka hopena o ke kolona).Hiki i nā ʻano maʻi ʻē aʻe ke hoʻopili i ke kolone. Hoʻopili kēia i ka lymph...